Table 2.
General characteristics for participants in the Sydney MAS cohort in which inflammatory analyses were performed
| Males, n = 448; mean (SD) or percentage with the condition | Females, n = 425; mean (SD) or percentage with the condition | Total sample, n = 873; mean (SD) or percentage with the condition | |
|---|---|---|---|
| Age | 78.76 (4.70) | 78.89 (4.92) | 78.84 (4.82) |
| Education | 12.30 (3.82)* | 11.04 (3.05)* | 11.59 (3.47) |
| Body Mass Index (kg/m2) | 27.61 (4.17)* | 26.64 (4.70)* | 27.08 (4.50) |
| Depression | 9.9% | 10.7% | 10.3% |
| Anginaa | 18.1%* | 8.9%* | 13% |
| Cerebrovascular accident (CVA)a | 5.9%* | 2.5%* | 4% |
| Acute myocardial infarction (AMI)a | 18.3%* | 6.2%* | 11.6% |
| Transient ischaemic attack (TIA)a | 6.3% | 7.2% | 6.8% |
| Past or current regular smoking | 67.9%* | 42.7%* | 54% |
| Alcohol consumption | * | * | |
| Abstainer | 8.4% | 15.9% | 12.5% |
| ≤1 drink per day | 44.5% | 61.7% | 54.1% |
| >1 drink per day | 47.5% | 22.2% | 33.4% |
| HDL-cholesterol | 1.29 (.39)* | 1.57 (.43)* | 1.44 (.44) |
| Hypertension | 58.6% | 62.8% | 61% |
| Triglycerides | 1.06 (.56) | 1.06 (.52) | 1.06 (.54) |
| Diabetes mellitus | 18.2%* | 9.4%* | 13.4% |
| Fasting blood glucose | * | * | |
| >10 mmol | 1.6% | 0.8% | 1.2% |
| 7.0–10 mmol | 12.4% | 6% | 9.2% |
| 5.6–6.9 mmol | 50.3% | 41.8% | 56.3% |
| <5.6 mmol | 35.7% | 51.4% | 42.7% |
| Apolipoprotein ε4 allele | 21% | 18.9% | 19.9% |
aIndicates variables determined by prior doctor diagnosis or confirmation
*p < 0.05 indicates a statistically significant difference between males and females